UK markets close in 1 hour 9 minutes

Dynavax Technologies Corporation (0IDA.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
9.12-0.08 (-0.87%)
As of 4:56PM BST. Market open.
Full screen
Previous close9.20
Open9.13
Bid0.00 x N/A
Ask0.00 x N/A
Day's range9.12 - 9.14
52-week range9.12 - 9.14
Volume2,950
Avg. volumeN/A
Market cap193.192M
Beta (5Y monthly)1.23
PE ratio (TTM)N/A
EPS (TTM)-0.58
Earnings date04 Aug 2021 - 09 Aug 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Why COVID Vaccine Stocks Dynavax, Novavax, and Vaxart Are Sinking Today
    Motley Fool

    Why COVID Vaccine Stocks Dynavax, Novavax, and Vaxart Are Sinking Today

    Dynavax Technologies (NASDAQ: DVAX) stock was down 6.3% as of 11:26 a.m. EDT, while shares of Novavax (NASDAQ: NVAX) and Vaxart (NASDAQ: VXRT) were falling 7.8% and 10.6%, respectively. The declines for the biotech stocks appear to merely be run-of-the-mill volatility on a day when the overall stock market was down. Sales of its Heplisav-B hepatitis B vaccine were negatively impacted by the COVID-19 pandemic.

  • Is Dynavax Technologies (NASDAQ:DVAX) Using Debt In A Risky Way?
    Simply Wall St.

    Is Dynavax Technologies (NASDAQ:DVAX) Using Debt In A Risky Way?

    Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

  • Why Dynavax Stock Is Rising Today
    Motley Fool

    Why Dynavax Stock Is Rising Today

    What happened Shares of Dynavax Technologies (NASDAQ: DVAX) were up by 3.6% as of 11:38 a.m. EDT on Thursday after having gained as much as 6.9% earlier in the session. The stock's rise came following the company's announcement that it has signed a deal with Bavarian Nordic to market and distribute its hepatitis B vaccine Heplisav B in Germany.